Home / Analysis kits / Imegen-PML-RARA

Imegen-PML-RARA

Description

Determination of the number of copies of the rearrangement PML-RARA t(15;17)(q22;q21) type bcr1 associated with Acute Promyelocytic Leukemia (APL)

Format

48×2 rxn (dehydrated/lyophilized)

Technology

Real-time PCR

Reference

IMG-111

Compatible equipment

7500 FAST Real-Time PCR System (ThermoFisher), StepOnePlus Real-Time PCR System (ThermoFisher)

Kit Health in Code
Request Kit
  • Quantitative assay to determine the number of copies of the PML-RARA t(15;17)(q22;q21) rearrangement type bcr1 and the number of copies of the endogenous GUS gene.
  • Allows detection of minimal residual disease (MD). The theoretical sensitivity level that can be achieved is MR4 (0.01% of PML-RARE).
  • High sensitivity and specificity: The limit of quantification (LOQ) has been set at 125 total copies for both the GUS reference gene and the PML-RARA rearrangement.
  • It includes an endogenous control of the GUS gene to be able to carry out the relative quantification. In addition, it allows to confirm the quality and integrity of the sample.
  • For use in research.

Real-time PCR analysis employing a combination of oligonucleotides and fluorescent hydrolysis probes for relative quantification of PML-RARA bcr1 rearrangement copy number relative to GUS reference gene copy number.

  • Amount of cDNA required: 20µL of cDNA resulting from the reverse transcription of 1 µg of RNA
  • Sample type: Peripheral blood
  • Number of reactions per sample: 4
  • Number of targets: 2
  • Manual working time: 45 min
  • Duration of the PCR program: 1h 15 min
  • Compatible cyclers: Real-time PCR cycler with the FAMTM
Imegen-PML-RARA: Instructions for use
Analysis certificate

Related kits

Imegen-PML-RARA Screening

IMG-130

Imegen-PML-RARA

Fill in the form to request this kit.

Call us at +34 963 212 340

Or write to us at info@healthincode.com

"*" indicates required fields

Consentimiento*
This field is for validation purposes and should be left unchanged.